{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"BioBreakthroughs","title":"#47 - Bill Peters, CEO at On Target Laboratories","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/a8693286\"></iframe>","width":"100%","height":180,"duration":911,"description":"Join us on the latest episode! Our Guest: Bill Peters, CEO at On Target Laboratories.What you'll get out of this episode:Innovative Imaging for Surgery – On Target Laboratories enables surgeons to see cancer at the cellular level using near-infrared imaging.Cytalux for Lung & Ovarian Cancer – Their FDA-approved drug, Cytalux, helps identify tumors in real-time, improving surgical outcomes.Surgeon-Driven Development – Continuous feedback from surgeons drives research, refining the technology for broader applications.Future of Cancer Surgery – With ongoing clinical trials, On Target Laboratories aims to expand its imaging technology to new indications.Industry Engagement – The company actively participates in key medical conferences, connecting with experts to advance cancer care.To Learn More About Our Guest And Their Company:Guest LinkedIn https://www.linkedin.com/in/bill-peters-749a332a/Company LinkedIn https://www.linkedin.com/company/on-target-laboratories-inc/ Website http://www.ontargetlabs.com Our sponsor for this episode are:Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/","thumbnail_url":"https://img.transistorcdn.com/roxGfgcNItysBs3fg55SsdSx4l_Pbz86Ktm2KMDYkR4/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzQwNjg1LzE2ODE5/MzQxODQtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}